Calibrated Regression Models Based on the Risk of Clinical Nodal Metastasis Should be Used as Decision Aids for Prostate Cancer Staging to Reduce Unnecessary Imaging

Abuzallouf, 2004, Baseline staging of newly diagnosed prostate cancer: a summary of the literature, J Urol, 171, 2122, 10.1097/01.ju.0000123981.03084.06 Hövels, 2008, The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis, Clin Radiol, 63, 387, 10.1016/j.crad.2007.05.022 Briganti, 2012, Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection, Eur Urol, 61, 1132, 10.1016/j.eururo.2011.11.008 Shinde, 2019, Node-positive nonmetastatic prostate cancer: time to reconsider prognostic staging?, Eur Urol, 75, 355, 10.1016/j.eururo.2018.09.017 Seisen, 2018, Efficacy of local treatment in prostate cancer patients with clinically pelvic lymph node-positive disease at initial diagnosis, Eur Urol, 73, 452, 10.1016/j.eururo.2017.08.011 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Prostate Cancer. Version 1.2022 ed: National Comprehensive Cancer Network. Erdem, 2022, Urol Oncol, 40, e1-6, 10.1016/j.urolonc.2021.07.006 Stabile, 2022, Eur Urol Oncol, 5, 1, 10.1016/j.euo.2021.08.001 Amiel, 2021, J Urol, 205, 1663, 10.1097/JU.0000000000001596 Memorial Sloan Kettering Cancer Center. Dynamic Prostate Cancer Nomogram: Coefficients. Updated January 14, 2020. https://www.mskcc.org/nomograms/prostate/pre_op/coefficients. Sarkar, 2019, Association between radical prostatectomy and survival in men with clinically node-positive prostate cancer, Eur Urol Oncol, 2, 584, 10.1016/j.euo.2018.09.015 Franklin, 2021, Histological comparison between predictive value of preoperative 3-T multiparametric MRI and (68) Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer, BJU Int, 127, 71, 10.1111/bju.15134 Petersen, 2020, PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review, Cancer Imaging, 20, 10, 10.1186/s40644-020-0290-9 Hofman, 2020, Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study, Lancet, 395, 1208, 10.1016/S0140-6736(20)30314-7 Centers for Medicare and Medicaid Services. Procedure Price Lookup. https://www.medicare.gov/procedure-price-lookup/.